IGC Pharma, Inc.
$0.29
$0.02 (+6.98%)
$0.27Day Range$0.29
Key Statistics
Market Cap
$27.54M
Shares Outstanding
103.4M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Apr 13, 2006
Round Lot
100
Locale
US
Trading Data
Day Open
$0.27
Day High
$0.29
Day Low
$0.27
Volume
811.7K
VWAP
$0.28
Prev Close
$0.27
Transactions
--
Acc. Volume
--
About IGC Pharma, Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
PHARMACEUTICAL PREPARATIONSSIC 283470 employees10224 FALLS ROAD, POTOMAC, MD, 20854301-529-4996IPO Apr 13, 2006US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001326205
- Composite FIGI
- BBG000NSSLY8
- Share Class FIGI
- BBG001SQQKX0
- Ticker Root
- IGC
- SIC Code
- 2834
About IGC Pharma, Inc. (IGC) Stock
IGC Pharma, Inc. (IGC) closed the 2026-09-18 session at $0.28, up 6.98% versus the previous close (+0.02). The stock opened at $0.27 and traded between $0.27 and $0.29 during that session. Session trading volume was 812K shares. The volume-weighted average price (VWAP) is $0.28.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
IGC Pharma, Inc. has a market capitalization of $27.5 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. IGC is listed on the XASE exchange. The company employs approximately 70 people. IGC Pharma, Inc. is headquartered in POTOMAC, MD. The recorded listing date is 2006-04-13.
On this page you can find market IGC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.